IP Library Granted Patent US 10,322,266
Granted Patent B2
US 10,322,266 · App. 15/723,067 · Granted Jun 18, 2019

Methods and devices for treatment of stenosis of arteriovenous fistula shunts

Inventors: James B. Laudenslager (Carlsbad, CA); Dean S. Irwin (Carlsbad, CA)
Assignee: Ra Medical Systems, Inc.
A61M25/09A61B18/245A61B50/30A61B2018/0041A61B2018/00285A61B2018/00577A61B2018/2222A61B2018/2238A61B2050/314A61B2090/3966A61M25/002A61M2025/0177A61M2025/105
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,322,266
App. No.
15/723,067
Granted
Jun 18, 2019
Kind
B2
Abstract

Devices and methods are discussed directed to the use of a low profile laser ablation catheter for use in laser ablation removal of arterial plaque blockages to restore blood flow in the treatment of arteriovenous fistulas. Also discussed are devices and methods directed to packaging, long term storage and sterilization of liquid core ablation catheters.

Claims (9)

1. A method of treating an arteriovenous fistula of a patient, comprising:

emitting pulsed ultraviolet laser ablation energy from a XeCl excimer laser at a nominal output wavelength of about 308 nm and a repetition rate of less than about 100 Hz into an input end of an ablation catheter;

transmitting the pulsed ultraviolet laser ablation energy through the ablation catheter;

axially advancing and guiding a distal end of the ablation catheter through a blockage that is disposed within or adjacent the arteriovenous fistula while emitting the pulsed ultraviolet laser ablation energy from an active emitting surface of the distal end of the ablation catheter while ablating and debulking the blockage, and

treating the blockage with a drug eluting balloon catheter after the distal end of the ablation catheter has traversed the blockage to improve long term patency of a lumen through the blockage.

2. The method of claim 1 wherein axially advancing and guiding the distal end of the ablation catheter comprises axially advancing and guiding the ablation catheter which further comprises a radiopaque marker band disposed on the distal end of the ablation catheter and further comprising imaging the distal end of the ablation catheter using fluoroscopy.

3. The method of claim 1 further comprising emitting red light from a red diode laser and the distal end of the ablation catheter and visualizing a position of the distal end of the ablation catheter using diffusion of the red light through the skin of the patient.

4. The method of claim 1 wherein guiding the distal end of the ablation catheter comprises advancing the distal end of the ablation catheter from a distal end of a support catheter comprising a deflectable distal section.

5. The method of claim 1 wherein axially advancing and guiding the distal end of the ablation catheter comprises axially advancing and guiding an ablation catheter comprising a liquid filled ultraviolet light transmitting catheter including a biocompatible liquid core, the liquid core being sealed at both ends with ultraviolet light transmitting windows which are crimped to a catheter body to seal in the liquid core.

Assignments (2)
MERGER Recorded Jul 26, 2018
From: RA MEDICAL SYSTEMS, INC. (A CALIFORNIA CORPORATION)
To: RA MEDICAL SYSTEMS, INC. (A DELAWARE CORPORATION)
Reel/Frame 046475/0442 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2017
From: LAUDENSLAGER, JAMES B.; IRWIN, DEAN S.
To: RA MEDICAL SYSTEMS, INC.
Reel/Frame 043783/0778 →
Continuity (3)
Division 14515435 · Oct 15, 2014
Provisional Application 61891830 · Oct 16, 2013
Related Publication 20180021552A1 · Jan 25, 2018